Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04870645Completed
Open-label, single-arm trial, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Contrast to Noise Ratio. Started Mar 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04870645.